| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 180,360 | 196,467 | ||
| Restricted cash | 55,000 | 55,000 | ||
| Accounts receivable | 7,951 | 17,204 | ||
| Prepaid expenses and other current assets | 5,889 | 5,832 | ||
| Total current assets | 249,200 | 274,503 | ||
| Property and equipment, gross | 19,390 | - | ||
| Less accumulated depreciation and amortization | 11,971 | - | ||
| Property and equipment, net | 7,419 | 8,088 | ||
| Operating lease right-of-use assets, net | 23,839 | 24,794 | ||
| Non-current restricted cash | 1,885 | 1,885 | ||
| Total assets | 282,343 | 309,270 | ||
| Accounts payable | 5,491 | 10,623 | ||
| Accrued liabilities | 19,382 | 24,629 | ||
| Deferred revenue | 6,826 | 11,263 | ||
| Total current liabilities | 31,699 | 46,515 | ||
| Deferred revenue, net of current portion | 4,220 | 8,769 | ||
| Operating lease liability, net of current portion | 21,865 | 22,933 | ||
| Total liabilities | 57,784 | 78,217 | ||
| Common stock, 0.001 par value 60,000 shares authorized issued and outstanding shares were 27,235 at september 30, 2025 and 27,096 at december 31, 2024 | 27 | 27 | ||
| Additional paid-in capital | 710,043 | 703,089 | ||
| Accumulated deficit | -485,511 | -472,063 | ||
| Total stockholders equity | 224,559 | 231,053 | ||
| Total liabilities and stockholders equity | 282,343 | 309,270 | ||
Arcturus Therapeutics Holdings Inc. (ARCT)
Arcturus Therapeutics Holdings Inc. (ARCT)